These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 9434809)
1. Emergence of drug-resistant tuberculosis in Jerusalem: ten-year retrospective review. Yinnon AM; Sasson A; Schlesinger Y; Raveh D; Jerassi Z; Rudensky B Isr J Med Sci; 1997 Nov; 33(11):728-33. PubMed ID: 9434809 [TBL] [Abstract][Full Text] [Related]
2. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis]. Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568 [TBL] [Abstract][Full Text] [Related]
3. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
4. Multidrug-resistant tuberculosis at Srinagarind Hospital, Khon Kaen, Thailand. Reechaipichitkul W Southeast Asian J Trop Med Public Health; 2002 Sep; 33(3):570-4. PubMed ID: 12693593 [TBL] [Abstract][Full Text] [Related]
5. Tuberculosis recurrence and mortality after successful treatment: impact of drug resistance. Cox H; Kebede Y; Allamuratova S; Ismailov G; Davletmuratova Z; Byrnes G; Stone C; Niemann S; Rüsch-Gerdes S; Blok L; Doshetov D PLoS Med; 2006 Oct; 3(10):e384. PubMed ID: 17020405 [TBL] [Abstract][Full Text] [Related]
6. A 10 year survey on Mycobacterium tuberculosis isolates in Israel and their drug resistance. Lavy A; Mates A Isr J Med Sci; 1994 Nov; 30(11):805-10. PubMed ID: 7982768 [TBL] [Abstract][Full Text] [Related]
7. Nature of drug resistance and predictors of multidrug-resistant tuberculosis among patients seen at the Philippine General Hospital, Manila, Philippines. Mendoza MT; Gonzaga AJ; Roa C; Velmonte MA; Jorge M; Montoya JC; Tan Torres T; Ong M; Barez MY; Ang CF Int J Tuberc Lung Dis; 1997 Feb; 1(1):59-63. PubMed ID: 9441060 [TBL] [Abstract][Full Text] [Related]
8. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance. Shamaei M; Marjani M; Chitsaz E; Kazempour M; Esmaeili M; Farnia P; Tabarsi P; Amiri MV; Mirsaeidi M; Mansouri D; Masjedi MR; Velayati AA Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897 [TBL] [Abstract][Full Text] [Related]
9. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis. Park SK; Kim JH; Kang H; Cho JS; Smego RA Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342 [TBL] [Abstract][Full Text] [Related]
10. Antibiotic resistant tuberculosis and bovine tuberculosis in an Irish hospital population (1991 to 2001). Min SM; Kelly P; Byrne C; Clancy L Ir Med J; 2005 Feb; 98(2):38-40. PubMed ID: 15835509 [TBL] [Abstract][Full Text] [Related]
11. [Frontier of mycobacterium research--host vs. mycobacterium]. Okada M; Shirakawa T Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793 [TBL] [Abstract][Full Text] [Related]
12. [Process of acquiring drug resistance: retrospective review of records of MDR TB]. Yoshiyama T; Ito K; Ogata H; Mitarai S; Hoshino H; Okumura M; Aman K; Aono A; Wada M Kekkaku; 2004 Dec; 79(12):717-24. PubMed ID: 15782617 [TBL] [Abstract][Full Text] [Related]
13. Drug resistant tuberculosis in Estonia. Kruuner A; Sillastu H; Danilovitsh M; Levina K; Svenson SB; Källenius G; Hoffner SE Int J Tuberc Lung Dis; 1998 Feb; 2(2):130-3. PubMed ID: 9562123 [TBL] [Abstract][Full Text] [Related]
14. Empirical treatment of community-acquired pneumonia and the development of fluoroquinolone-resistant tuberculosis. Long R; Chong H; Hoeppner V; Shanmuganathan H; Kowalewska-Grochowska K; Shandro C; Manfreda J; Senthilselvan A; Elzainy A; Marrie T Clin Infect Dis; 2009 May; 48(10):1354-60. PubMed ID: 19348594 [TBL] [Abstract][Full Text] [Related]
15. Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis. Becerra MC; Freeman J; Bayona J; Shin SS; Kim JY; Furin JJ; Werner B; Sloutsky A; Timperi R; Wilson ME; Pagano M; Farmer PE Int J Tuberc Lung Dis; 2000 Feb; 4(2):108-14. PubMed ID: 10694087 [TBL] [Abstract][Full Text] [Related]
16. Risk factors for drug-resistant Mycobacterium tuberculosis in Saudi Arabia. Alrajhi AA; Abdulwahab S; Almodovar E; Al-Abdely HM Saudi Med J; 2002 Mar; 23(3):305-10. PubMed ID: 11938422 [TBL] [Abstract][Full Text] [Related]
18. Aerosolized interferon-alpha treatment in patients with multi-drug-resistant pulmonary tuberculosis. Giosuè S; Casarini M; Ameglio F; Zangrilli P; Palla M; Altieri AM; Bisetti A Eur Cytokine Netw; 2000 Mar; 11(1):99-104. PubMed ID: 10705306 [TBL] [Abstract][Full Text] [Related]
19. Drug resistance pulmonary tuberculosis in the Eastern Province of Saudi Arabia. Al-Rubaish AM; Madania AA; Al-Muhanna FA Saudi Med J; 2001 Sep; 22(9):776-9. PubMed ID: 11590451 [TBL] [Abstract][Full Text] [Related]
20. The resistance to major antituberculous drugs of Mycobacterium tuberculosis strains isolated from the respiratory system specimens of tuberculosis patients in Duzce, Turkey. Ozturk CE; Balbay OA; Kaya D; Ceyhan I; Bulut I; Sahin I Jpn J Infect Dis; 2005 Feb; 58(1):47-9. PubMed ID: 15728994 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]